"If the [fetal] organs are available, it is better to use them to save somebody's life rather than throw them into the trash bin."UPDATE 8/6/15: 'Humanized Mice' Created with Aborted Babies for Gay Agenda (using taxpayer$$)
-- Eugene Gu, CEO of Ganogen, Inc., Redwood City, CA
For background, click headlines below to read previous articles:
Harvesting Blood of Children for Fountain of Youth
Type 1 Diabetics' Hope Rests in Dead Human Embryos
Human Embryos Cloned, Killed to Harvest Stem Cells
Boy 'Created' Artificially to Cure Sister's Disease
-- From "Coming age of Xenotransplantation: Would you accept an organ from a pig to save your life?" by David Warmflash, Genetic Literacy Project 2/12/15
A shortage of organs means a shortage of organs from human donors, and in the years to come, non-human organs may be used to fill the gap. Known as xenotransplantation, the idea of grafting organs from non-human animals to human patients is not new, but historically, it’s been essentially a surgical research tool.
As the technology has advanced, researchers have begun developing a technique that could get more kidneys to people who need transplants. But the method is controversial: It is now feasible to remove a kidney from an aborted human fetus and implant the organ into a rat, where the kidney can grow to a larger size. It’s possible that further work could find a way to grow kidneys large enough that they could be transplanted into a person, the researchers said, although much more research is needed to determine whether this could be done.
“Our long-term goal is to grow human organs in animals, to end the human donor shortage,” said study co-author Eugene Gu, a medical student at Duke University and the founder and CEO of Ganogen, Inc., a biotech company in Redwood City, California.
As for how people feel about xenotransplanation, a poll conducted at the turn of the century found 71 percent of the public saying that they would consider xenotransplantation for a family member, if no human organ match were available. But there is also the animal rights objection.
To read the entire article above, CLICK HERE.
From "Kidney Harvested From Aborted Human Fetus Grown In Rat: An End To Organ Donor Shortage, Scientists Say" by Susan Scutti, Medical Daily 1/23/15
“We feel that our research is more palatable than all the other researchers who use taxpayer money to fund their research involving aborted human fetal tissues, which is the vast majority of major biomedical research labs,” Gu tells Medical Daily. In fact, Gu and his research team acquired the fetal kidneys used in their experiments from Stem Express, a self-described “multi-million dollar company that supplies human blood, tissue products, primary cells, and other clinical specimens to biomedical researchers around the world.”
“We did this study in rats as proof-of-concept to show that human fetal organs can indeed survive in an animal host, can function to keep the animal alive, and can grow larger over time,” Gu says. Indeed: the rats survived roughly four months after the transplant, and one even lived for 10 months.
Among the ethical questions raised by Gu's work is whether the use of human fetal organs in research should be permissible and whether it is right to transplant human organs into animals. The Ganogen website argues that, as personalized medicine advances and becomes increasingly prevalent, “the differences between mice and men can no longer be ignored.” The reason? Simple animal testing of new drugs, which increasingly target highly specific proteins or genetic variations, cannot sufficiently safeguard our human health. The drug Herceptin is their case in point. This commonly prescribed breast cancer drug caused heart failure in some patients after extensive animal testing proved it safe.
To read the entire article above, CLICK HERE.
From "Aborted baby organs to be used to grow transplants for medical patients" by Ethan A. Huff, Staff Writer, Natural News 3/3/15
Set to be published in the American Journal of Transplantation, a study on the process shows that it is entirely possible to cultivate living organs inside the bodies of animals. Whether these synthetically derived organs will be accepted by the bodies of actual human donors is still unknown, but researchers believe that the concept is promising for achieving their goals.
After obtaining human fetal kidneys from Stem Express, a California-based company that supplies researchers with various tissues harvested from both dead babies and adults, Gu and his colleagues implanted them into rats deliberately bred without immune systems. If the rats had had immune systems, their bodies likely would have rejected the foreign organs.
Earlier research has attempted to grow immature human kidneys in the abdomens of mice, but this latest study represents the first time that whole organs have been successfully sown inside animals. If the process proves to be successful on a larger scale, it forebodes a future in which aborted human babies become a commercial commodity for companies to capitalize on artificial organ development.
To read the entire article above, CLICK HERE.
From "Scientists grow kidneys of aborted babies in animals" by Bob Unruh, World Net Daily 3/3/15
A video by Ganogen glosses over the source of the organs by euphemistically calling them “discarded.” But obtaining viable human organs requires working in concert with abortion businesses.
Ganogen says it already is working on the processes for kidney transplants as well as human fetal heart transplantation.
Jim Sedlak, spokesman for the American Life League, the largest grassroots Catholic pro-life movement in the U.S., called the transplant program “totally immoral” and “another outlandish use of aborted babies to produce results that humans think are good.”
“We are totally opposed to any use of aborted cells from human beings to grow organs or for any other purpose,” he said. “Someone died in order for these organs to be grown.”
To read the entire article above, CLICK HERE.
Also read Obama Administration OKs Aborted Baby Brain Experiments
And read President Obama's FDA: Why not Three Biological Parents?
